BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17501911)

  • 1. Expression of Thy 1.2 surface antigen increases significantly during the murine mesenchymal stem cells cultivation period.
    Eslaminejad MB; Nadri S; Hosseini RH
    Dev Growth Differ; 2007 May; 49(4):351-64. PubMed ID: 17501911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine mesenchymal stem cells isolated by low density primary culture system.
    Eslaminejad MB; Nikmahzar A; Taghiyar L; Nadri S; Massumi M
    Dev Growth Differ; 2006 Aug; 48(6):361-70. PubMed ID: 16872449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An efficient method for isolation of murine bone marrow mesenchymal stem cells.
    Nadri S; Soleimani M; Hosseni RH; Massumi M; Atashi A; Izadpanah R
    Int J Dev Biol; 2007; 51(8):723-9. PubMed ID: 17939119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection.
    Baddoo M; Hill K; Wilkinson R; Gaupp D; Hughes C; Kopen GC; Phinney DG
    J Cell Biochem; 2003 Aug; 89(6):1235-49. PubMed ID: 12898521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method.
    Sun S; Guo Z; Xiao X; Liu B; Liu X; Tang PH; Mao N
    Stem Cells; 2003; 21(5):527-35. PubMed ID: 12968107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multilineage differentiation potential of human dermal skin-derived fibroblasts.
    Lorenz K; Sicker M; Schmelzer E; Rupf T; Salvetter J; Schulz-Siegmund M; Bader A
    Exp Dermatol; 2008 Nov; 17(11):925-32. PubMed ID: 18557932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characteristics and in vivo immunosuppressive activity of compact bone-derived murine mesenchymal progenitor cells.
    Guo Z; Li H; Li X; Yu X; Wang H; Tang P; Mao N
    Stem Cells; 2006 Apr; 24(4):992-1000. PubMed ID: 16644925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of fibroblast-like cells from the rat olfactory bulb.
    Soleimani M; Nadri S; Salehi M; Sobhani A; Hajarizadeh A
    Int J Dev Biol; 2008; 52(7):979-84. PubMed ID: 18956328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose-derived stem cell: a better stem cell than BMSC.
    Zhu Y; Liu T; Song K; Fan X; Ma X; Cui Z
    Cell Biochem Funct; 2008 Aug; 26(6):664-75. PubMed ID: 18636461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of mouse mesenchymal stem cells.
    Sung JH; Yang HM; Park JB; Choi GS; Joh JW; Kwon CH; Chun JM; Lee SK; Kim SJ
    Transplant Proc; 2008 Oct; 40(8):2649-54. PubMed ID: 18929828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model.
    Kyriakou C; Rabin N; Pizzey A; Nathwani A; Yong K
    Haematologica; 2008 Oct; 93(10):1457-65. PubMed ID: 18728032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation potential of bone marrow mesenchymal stem cells in duck.
    Li L; Bai X; Gong X; Liu H; Chen L; Guan W; Ma Y
    J Genet Genomics; 2009 Mar; 36(3):133-40. PubMed ID: 19302969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BM cells giving rise to MSC in culture have a heterogeneous CD34 and CD45 phenotype.
    Kaiser S; Hackanson B; Follo M; Mehlhorn A; Geiger K; Ihorst G; Kapp U
    Cytotherapy; 2007; 9(5):439-50. PubMed ID: 17786605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
    Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
    Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of mesenchymal stem cells from murine bone marrow by immunodepletion.
    Phinney DG
    Methods Mol Biol; 2008; 449():171-86. PubMed ID: 18370091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypic changes of human articular chondrocytes during monolayer culture reflect bona fide dedifferentiation rather than amplification of progenitor cells.
    Diaz-Romero J; Nesic D; Grogan SP; Heini P; Mainil-Varlet P
    J Cell Physiol; 2008 Jan; 214(1):75-83. PubMed ID: 17559082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
    Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
    Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotypic expression by flow cytometric analysis of cocultured skeletal muscle and bone marrow mesenchymal stem cells for therapy into myocardium.
    Carvalho KA; Oliveira L; Malvezzi M; Simeoni RB; Francisco JC; Olandoski M; Guarita-Souza LC
    Transplant Proc; 2008 Apr; 40(3):842-4. PubMed ID: 18455032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics.
    Campioni D; Lanza F; Moretti S; Ferrari L; Cuneo A
    Cytotherapy; 2008; 10(1):69-82. PubMed ID: 18202976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of mesenchymal stromal cells from murine bone marrow and amniotic fluid.
    Nadri S; Soleimani M
    Cytotherapy; 2007; 9(8):729-37. PubMed ID: 17917881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.